NEVRO CORP. Business Combination, Contingent Consideration, Liability
NEVRO CORP. had Business Combination, Contingent Consideration, Liability of $5.41 million as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2025-03-04
- 2024-12-31: Business Combination, Contingent Consideration, Liability $5.41M.
- 2024-09-30: Business Combination, Contingent Consideration, Liability $15.41M.
- 2024-06-30: Business Combination, Contingent Consideration, Liability $16.72M.
- 2024-03-31: Business Combination, Contingent Consideration, Liability $15.78M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2024-12-31 | $5.41M 10-K · filed 2025-03-04 |
| 2024-09-30 | $15.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $16.72M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $15.78M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $22.09M 10-K · filed 2025-03-04 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-04 |